Form D · Biotechnology
Cancer Prevention Pharmaceuticals, Inc.
Tucson, AZ · CIK 0001471002
Offering snapshot reported Jan 29, 2021 · SEC filing
- Reported sold
- $400K Offering amount: $3M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 20, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 29, 2021 | Initial | $400,000 | No comparison | 6 | SEC filing |
| Sep 14, 2017 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Apr 25, 2017 | Initial | $700,000 | No comparison | 8 | SEC filing |
| Jan 22, 2016 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jan 14, 2016 | Initial | $835,000 | No comparison | 14 | SEC filing |
| Oct 31, 2013 | Amendment | $4,272,500 | $3,917,500vs Nov 19, 2012 | 6 | SEC filing |
| Nov 19, 2012 | Initial | $355,000 | No comparison | 2 | SEC filing |
| Mar 24, 2011 | Initial | $550,000 | No comparison | 12 | SEC filing |
| Sep 1, 2009 | Initial | $1,250,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-387825
Source: Form D, filed Jan 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Donovan | Director |
| Eugene W Gerner | Director, Executive |
| Eugene Gerner, Ph.D. | Director |
| Jeffrey Jacob | Director, Executive |
| Andrew Levitch | Executive |
| Richard Love | Director |
| Frank Meyskens | Director |
| Christopher Richied | Executive |
| Jon Saxe | Director |
| John Saxe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1760 East River Road, Suite 250
Tucson, AZ, 85718
Tucson, AZ, 85718